Aurinia Pharmaceuticals (AUPH) had the highest return between July 1, 2013 and December 31, 2013 by a mid-cap US stock, returning 7,464.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Aurinia Pharmaceuticals (AUPH) | 7/1/2013 - 12/31/2013 | 7,464.69% |
Iovance Biotherapeutics (IOVA) | 7/1/2013 - 12/31/2013 | 425% |
BioCryst Pharmaceuticals (BCRX) | 7/1/2013 - 12/31/2013 | 387.18% |
Plug Power (PLUG) | 7/1/2013 - 12/31/2013 | 287.5% |
Himax Technologies (HIMX) | 7/1/2013 - 12/31/2013 | 193.04% |
Vipshop (VIPS) | 7/1/2013 - 12/31/2013 | 182.51% |
Star Bulk Carriers (SBLK) | 7/1/2013 - 12/31/2013 | 144.59% |
Aehr Test Systems (AEHR) | 7/1/2013 - 12/31/2013 | 127.21% |
Sellas Life Sciences (SLS) | 7/1/2013 - 12/31/2013 | 121.43% |
Stagwell (STGW) | 7/1/2013 - 12/31/2013 | 115.25% |
TAL Education (TAL) | 7/1/2013 - 12/31/2013 | 110.43% |
Grupo Financiero Galicia SA ADR (GGAL) | 7/1/2013 - 12/31/2013 | 102.91% |
Extreme Networks (EXTR) | 7/1/2013 - 12/31/2013 | 100% |
Ambarella (AMBA) | 7/1/2013 - 12/31/2013 | 99.94% |
AtriCure (ATRC) | 7/1/2013 - 12/31/2013 | 96.63% |
Perdoceo Education (PRDO) | 7/1/2013 - 12/31/2013 | 96.55% |
Vicor (VICR) | 7/1/2013 - 12/31/2013 | 93.65% |
BBVA Banco Frances SA ADR (BBAR) | 7/1/2013 - 12/31/2013 | 85.6% |
JOYY (JOYY) | 7/1/2013 - 12/31/2013 | 82.9% |
Argan (AGX) | 7/1/2013 - 12/31/2013 | 80.76% |
HCI (HCI) | 7/1/2013 - 12/31/2013 | 74.57% |
Riot Platforms (RIOT) | 7/1/2013 - 12/31/2013 | 73.99% |
DXP Enterprises (DXPE) | 7/1/2013 - 12/31/2013 | 72.77% |
Chefs Warehouse (CHEF) | 7/1/2013 - 12/31/2013 | 68.95% |
Camtek (CAMT) | 7/1/2013 - 12/31/2013 | 68.74% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.